Coherus Oncology: Fourth Quarter Financial Results Overview

Coherus Oncology, Inc. Reports Fourth Quarter Financial Results

Coherus Oncology, based in Redwood City, California, announced on Monday that it recorded a net loss of $37.6 million for the fourth quarter.

The company reported a loss of $0.31 per share for the quarter. After adjusting for non-recurring items, the loss amounted to $0.34 per share.

During the same period, Coherus Oncology generated $12.7 million in revenue, which did not meet the expectations of analysts surveyed by Zacks, who had projected $13.1 million.

For the full year, the company achieved a profit of $168 million, or $1.43 per share, with total revenue reaching $42.2 million.